ThyroSeq Hits Target NPV


As part of its coverage for the 84th Annual Meeting of the American Thyroid Association, MedPage Today attended oral presentations about ThyroSeq v.2 and reported on the exciting promise for the test with a significant negative predictive value (NPV) of 96%.

To read the MedPage Today article, please visit:

To learn more about ThyroSeq v.2, please click here.